Needham & Company LLC Reiterates “Hold” Rating for Amicus Therapeutics (NASDAQ:FOLD)
Needham & Company LLC reiterated their hold rating on shares of Amicus Therapeutics (NASDAQ:FOLD – Free Report) in a report released on Thursday morning,Benzinga reports. FOLD has been the subject of a number of other reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $21.00 price objective on shares of Amicus Therapeutics in a […]
Needham & Company LLC reiterated their hold rating on shares of Amicus Therapeutics (NASDAQ:FOLD – Free Report) in a report released on Thursday morning,Benzinga reports. FOLD has been the subject of a number of other reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $21.00 price objective on shares of Amicus Therapeutics in a […]
